Bejelentkezés
Magyar
Toggle navigation
Tudóstér
Bejelentkezés
Magyar
Tudóstér
Keresés
Egyszerű keresés
Összetett keresés
CCL keresés
Egyszerű keresés
Összetett keresés
CCL keresés
Böngészés
Saját polc tartalma
(
0
)
Korábbi keresések
CCL parancs
CCL
Összesen 2 találat.
#/oldal:
12
36
60
120
Rövid
Hosszú
MARC
Részletezés:
Rendezés:
Szerző növekvő
Szerző csökkenő
Cím növekvő
Cím csökkenő
Dátum növekvő
Dátum csökkenő
1.
001-es BibID:
BIBFORM103907
035-os BibID:
(Scopus)85137319107 (WoS)000833275600001
Első szerző:
Lococo, Filippo
Cím:
Does Myasthenia Gravis Affect Long-Term Survival in Thymic Carcinomas? An ESTS DatabaseAnalysis / Filippo Lococo, Dania Nachira, Marco Chiappetta, Jessica Evangelista, Pierre Emmanuel Falcoz, Enrico Ruffini, Paul Van Schil, Marco Scarci, József Furák, Francesco Sollitto, Francesco Guerrera, Lorenzo Spaggiari, Clemens Aigner, Liverakou Evangelia, Andrea Billé, Bernhard Moser, Pascal Alexandre Thomas, Moishe Liberman, Souheil Boubia, Alessio Campisi, Luca Ampollini, Alper Toker, Attila Enyedi, Luca Voltolini, Dirk Van Raemdonck, Stefano Margaritora, ESTS Thymic Working Group
Dátum:
2022
Tárgyszavak:
Orvostudományok
Elméleti orvostudományok
idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:
Diagnostics. - 12 : 7 (2022), p. 1-12. -
További szerzők:
Nachira, Dania
Chiappetta, Marco
Evangelista, Jessica
Falcoz, Pierre Emmanuel
Ruffini, Enrico
Van Schil, Paul
Scarci, Marco
Furák József
Sollitto, Francesco
Guerrera, Francesco
Spaggiari, Lorenzo
Aigner, Clemens
Evangelia, Liverakou
Billé, Andrea
Moser, Bernhard
Thomas, Pascal Alexandre
Liberman, Moishe
Boubia, Souheil
Campisi, Alessio
Ampollini, Luca
Toker, Alper
Enyedi Attila (1975-) (sebész)
Voltolini, Luca
Van Raemdonck, Dirk
Margaritora, Stefano
ESTS Thymic Working Group
Internet cím:
Intézményi repozitóriumban (DEA) tárolt változat
DOI
Borító:
Saját polcon:
2.
001-es BibID:
BIBFORM120622
035-os BibID:
(Scopus)85128187085 (WoS)000862476100016
Első szerző:
Mendogni, Paolo
Cím:
Surgical resection of Masaoka stage III thymic epithelial tumours with great vessels involvement : a retrospective multicentric analysis from the European Society of Thoracic Surgeons thymic database / Paolo Mendogni, Alper Toker, Bernhard Moser, Florentino Hernando Trancho, Clemens Aigner, Ivan Gomes Bravio, Nuria Maria Novoa, Laureano Molins, Lorena Costardi, Luca Voltolini, Nicoletta Pia Ardò, Bram Verdonck, Luca Ampollini, Charlambos Zisis, Vitaly Barmin, Attila Enyedi, Enrico Ruffini, Dirk Van Raemdonck, Pascal-Alexandre Thomas, Walter Weder, Gaetano Rocco, Alessandro Brunelli, Frank C. Detterbeck, Federico Venuta, Pierre-Emmanuel Falcoz, Davide Tosi, Gianluca Bonitta, Mario Nosotti, European Association of Thoracic Surgeons (ESTS) Thymic Working Group Participating Centers
Dátum:
2022
ISSN:
1010-7940
Megjegyzések:
OBJECTIVES: The aim of this study was to analyse the outcomes of an international cohort of patients affected by Masaoka stage III thymic epithelial tumours with vascular involvement and treated by surgery. METHODS: Study design was the observational multicentre retrospective cohort study. Data were extracted from the European Society of Thoracic Surgeons thymic database; additional variables were collected. Inclusion criteria were as follows: stage III (Masaoka-Koga) thymic epithelial tumours; surgery with radical intention; clinical or pathological great vessels involvement; and radiologically suspected or diagnosed intraoperatively. Outcome items were analysed. RESULTS: Sixty-five patients submitted to surgery from 2001 to 2017 fulfilled inclusion criteria. Thymoma and thymic carcinoma patients did not differ for demographics and clinical characteristics. The majority of great vessel treated were superior vena cava or innominate veins (72.3%). Eleven patients (16.9%) had postoperative cardiopulmonary complications; vascular stenosis was observed in 3 patients (4.6%). The multivariable Cox analysis for disease-free survival showed an increased hazard of recurrence for thymic carcinoma (hazard ratio = 3.59; 95% confidence interval: 1.66-7.78, P = 0.001). The 1-, 3-, 5-and 10-year overall survival rates were 0.86, 0.84, 0.81, and 0.53, respectively. There was no significant difference in overall survival according to resection status or between thymoma and thimic carcinoma. The univariable Cox regression model did not show an increased hazard of death for myasthenic patients considering all resection status and for patients who received neoadjuvant therapy. CONCLUSIONS: We observed that clinical outcomes of patients treated for stage III thymic epithelial tumours with vascular involvement are satisfactory suggesting to increase the confidence in dealing with these complex surgeries. Complete resection should be achieved, even though extensive vascular reconstructions are required.
Tárgyszavak:
Orvostudományok
Klinikai orvostudományok
idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Thymic tumours
Thymoma
Great vessels
Thymectomy
Recurrence
Survival
Megjelenés:
European Journal Of Cardio-Thoracic Surgery. - 62 : 4 (2022), p. 1-11. -
További szerzők:
Toker, Alper
Moser, Bernhard
Trancho, Florentino Hernando
Aigner, Clemens
Bravio, Ivan Gomes
Novoa, Nuria Maria
Molins, Laureano
Costardi, Lorena
Voltolini, Luca
Ardò, Nicoletta Pia
Verdonck, Bram
Ampollini, Luca
Zisis, Charlambos
Barmin, Vitaly
Enyedi Attila (1975-) (sebész)
Ruffini, Enrico
Raemdonck, Dirk Van
Thomas, Pascal Alexandre
Weder, Walter
Rocco, Gaetano
Brunelli, Alessandro
Detterbeck, Frank C.
Venuta, Federico
Falcoz, Pierre-Emmanuel
Tosi, Davide
Bonitta, Gianluca
Nosotti, Mario
Ozkan, Berker
Cmenoglu, Berk
Thanner, Jürgen
Olivero, Carlos Fraile
Alvarado, Rodriguez
Boada, Marc
Bongiolatti, Stefano
Sollitto, Francesco
Schil, Paul Van
Bocchialini, Giovanni
Brioude, Geoffrey
European Association of Thoracic Surgeons (ESTS) Thymic Working Group Participating Centers
Internet cím:
Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:
Rekordok letöltése
1
Corvina könyvtári katalógus v10.11.18-SNAPSHOT
© 2024
Monguz kft.
Minden jog fenntartva.